Ausgabe 6/2004
Inhalt (11 Artikel)
Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine
Hui Wang, Mao Li, John J. Rinehart, Ruiwen Zhang
Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule
Lloyd E. Damon, Laura J. Johnston, Curt A. Ries, Hope S. Rugo, Delvyn Case, Kenneth Ault, Charles A. Linker
The effects of degree of hepatic or renal impairment on the pharmacokinetics of exemestane in postmenopausal women
Maria Gabriella Jannuzzo, Italo Poggesi, Riccardo Spinelli, Maurizio Rocchetti, Paolo Cicioni, Peter Buchan
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101
P. C. Adamson, S. M. Blaney, B. C. Widemann, B. Kitchen, R. F. Murphy, A. L. Hannah, G. F. Cropp, M. Patel, A. F. Gillespie, P. G. Whitcomb, F.M. Balis
A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study
Véronique Diéras, Jean Paul Guastalla, Jean Marc Ferrero, Hervé Curé, Béatrice Weber, Philippe Winckel, Alain Lortholary, Françoise Mayer, Désiré Paraiso, Emmanuelle Magherini, Eric Pujade-Lauraine
Investigations on the pharmacokinetics of trofosfamide and its metabolites—first report of 4-hydroxy-trofosfamide kinetics in humans
Rainer Preiss, Frank Baumann, Dragan Stefanovic, Ulf Niemeyer, Wolfgang Pönisch, Dietger Niederwieser
Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies
Philippe Mougenot, Frédéric Pinguet, Michel Fabbro, Stéphane Culine, Sylvain Poujol, Cécile Astre, Françoise Bressolle
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer
Steven J. Cohen, James Gallo, Nancy L. Lewis, R. Katherine Alpaugh, Louis Gentner, André Rogatko, Gwen Yeslow, Jessie Schol, Tom Verhaeghe, Peter Zannikos, Peter A. Palmer, Louis M. Weiner, Neal J. Meropol
Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line
Kin-Tak Chan, Maria Li Lung
Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates
Patrick A. Thompson, Stacey L. Berg, Alexander Aleksic, Jody Z. Kerr, Leticia McGuffey, Robert Dauser, Jed G. Nuchtern, Fred Hausheer, Susan M. Blaney
Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines
Patricia García-López, Mauricio Rodríguez-Dorantes, Enrique Pérez-Cárdenas, Marco Cerbón, Alejandro Mohar-Betancourt